18 years. 28 publications. One researcher who never stopped.
The science behind Escozul® is not a marketing claim. It is a documented,
peer-reviewed, internationally recognized body of research led by one of
the world’s most specialized scientists in blue scorpion venom
compounds.
DIRECTOR OF RESEARCH & DEVELOPMENT
Dr. Alexis Diaz has dedicated his entire scientific career to a single subject: the biological properties of blue scorpion venom fractions.
Today he is the world’s most published and specialized researcher on Heteroctenus junceus with over 25 peer-reviewed scientific articles, two international patent applications filed under the Patent Cooperation Treaty, and active research partnerships with universities across three continents.
He is the co-inventor of both PCT patent applications published by WIPO in November 2025, and the scientific foundation upon which every Escozul® protocol is built.
18+ years exclusively on blue
scorpion venom compounds
25+ peer-reviewed scientific
publications
Co-inventor — WO2025241039 +
WO2025241040 (PCT/WIPO, 2025)
8 active international university
partnerships
RESEARCH AREAS
What the research shows
Over 18 years, the research program led by Dr. Diaz has systematically studied the behavior of specific
fractions of blue scorpion venom in controlled experimental settings — analyzing their biological properties,
toxicological profile, stability, and potential applications.
Biological Fractions
Research focuses on fractions F4
and F5.3 of Heteroctenus junceus
venom — identifiable, reproducible
compounds studied under
controlled laboratory conditions
with defined biological properties.
Toxicological Profile
Studies have analyzed the safety
profile of these fractions, including
cardiac toxicity evaluations and
antimicrobial stability assessments,
providing essential data for
responsible protocol development.
Experimental Applications
Research has examined the
behavior of these fractions in
experimental models, including
studies related to cellular
processes. All findings are
documented in peer-reviewed
publications and form the basis of
the two active PCT patent
applications.
All research described represents experimental and scientific findings. No claims are made regarding the diagnosis, treatment, cure, or prevention of any disease.
SCIENTIFIC PUBLICATIONS
28 published scientific articles
The following publications document the ongoing research
program on blue scorpion venom fractions conducted by Dr.
Alexis Diaz and collaborating institutions.
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
Principal articles links with truncate text
INTERNATIONAL PARTNER INSTITUTIONS
8 international research
agreements
The Escozul® research program operates through formal
scientific agreements with universities and research institutions
across Latin America and Europe.
The science is the foundation. The
protocol is the access
18 years of research, two international patent applications, and 600+ documented
cases — available to you through a structured, personally guided wellness protocol.